Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma

Background: Glioma is one of the most aggressive cancer types affecting the central nerve system, with poor overall survival (OS) rates. The present study aimed to construct a novel immune-related signature to predict prognosis and the efficiency of immunotherapy in patients with glioma. Methods: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Sibin, Xiao, Xu, Wang, Yu, Song, Tianjun, Li, Chenlong, Bao, Hongbo, Liu, Qing, Sun, Guiyin, Sun, Xiaoyang, Su, Tianqi, Fu, Tianjiao, Wang, Yujie, Liang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204856/
https://www.ncbi.nlm.nih.gov/pubmed/35719378
http://dx.doi.org/10.3389/fgene.2022.899125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204856/
https://www.ncbi.nlm.nih.gov/pubmed/35719378
http://dx.doi.org/10.3389/fgene.2022.899125

Ejemplares similares